WO2010136360A2 - Benzylidene malonates - Google Patents
Benzylidene malonates Download PDFInfo
- Publication number
- WO2010136360A2 WO2010136360A2 PCT/EP2010/056843 EP2010056843W WO2010136360A2 WO 2010136360 A2 WO2010136360 A2 WO 2010136360A2 EP 2010056843 W EP2010056843 W EP 2010056843W WO 2010136360 A2 WO2010136360 A2 WO 2010136360A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wat
- sol
- methyl
- liq
- butyl
- Prior art date
Links
- 0 *OC(C(C(O*)=O)=Cc(cc1)ccc1O*)=O Chemical compound *OC(C(C(O*)=O)=Cc(cc1)ccc1O*)=O 0.000 description 2
- CFJYNSNXFXLKNS-UHFFFAOYSA-N CC(C)C1CCC(C)CC1 Chemical compound CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
Definitions
- the present invention relates to the use of specific monomeric benzylidene malonates for cosmetic preparations and new monomeric benzylidene malonates.
- UV radiation is harmful to human skin.
- UV-B radiation (about 290 to about 320 nm) is responsible for sunburn and can cause skin cancer.
- UV-A radiation (about 320 to about 400 nm) while producing tanning of the skin, contributes also to sunburn and the induction of skin cancers.
- UV-A radiation may be aggravated by UV-A radiation.
- an effective sunscreen formulation preferably comprises both at least one UV-A and UV-B filter and a broad band UV filter covering the full range from about 290nm to about 400 nm to prevent the human skin from the damage of sunlight.
- UV filters Besides their screening power on solar radiation UV filters must also have good resistance to water and perspiration and also satisfactory photostability.
- UV filters like Butyl Methoxydibenzoylmethane (sold under the tradename "Parsol 1789” by DSM) which have the particularity and also the disadvantage of being solid at ambient temperature.
- their use in sunscreen cosmetic compositions implies certain constraints in terms of their formulation and their use, in particular the selection of specific suitable cosmetic solvents that afford a proper solubility of these UV filters.
- a UV filter should show high solubility in common cosmetic oils or should be a good solvent for other UV filters that show poor oil solubility.
- the oil soluble UV filters should be included in cosmetic sun care products without any impact on the sensorial characteristic of the emulsion. For that reason the optimal distribution of the UV absorber within the hydro-lipid film left on the skin after spreading should be guaranteed. It is therefore an object of the present invention to find UV absorber formulations which have improved properties regarding the UV absorber.
- the present invention relates to the use of benzylidene malonates of formula
- R 1 is methyl; ethyl; propyl; or n-butyl; if R 1 is methyl, then
- R is tert. butyl; ; a radical of formula
- R 2 and R 3 independently from each other are hydrogen; or methyl;
- R 4 is methyl; ethyl; or n-propyl
- R 5 and R 6 independently from each other are hydrogen; or CrC 3 alkyl; if R 1 is ethyl; propyl; or n-butyl, then
- R is isopropyl
- R 1 is methyl; ethyl; propyl; or n-butyl; if R 1 is methyl, then R is tert. butyl; ; a radical of formula (1a) ; or a
- R 2 and R 3 independently from each other are hydrogen; or methyl;
- R 4 is methyl; ethyl; or n-propyl;
- R 5 and R 6 independently from each other are hydrogen; or d-C 3 alkyl; if R 1 is ethyl; propyl; or n-butyl, then R is isopropyl.
- R is a radical of formul
- R 1 is methyl
- R 1 is ethyl; propyl; or n-butyl; and R is isopropyl.
- the present invention also refers to novel monomeric benzylidene compounds. These compounds correspond to formula
- R ⁇ methyl; ethyl; propyl; or n-butyl; if R'-i is methyl, then
- R' is tert. butyl; or a radical of formula (Va) ; or a
- R' 2 and R' 3 independently from each other are hydrogen; or methyl; R' 4 is methyl; ethyl; or n-propyl; if R ⁇ is ethyl; or propyl; then R' is isopropyl.
- R' is a radical of formula
- R'i is methyl
- benzylidene malonates according to the present invention are prepared in a manner known per se according to the following reaction scheme:
- Solvents used in this step are for example benzene, toluene, o-xylene, m-xylene, p-xylene, chloroform, dichloromethane, ethanol, methanol, tetrahydrofurane, acetonitrile, ethyl acetate, CCI 4 , cyclohexane, n-hexane, n-pentane, or ionic liquids as for example 1-methyl-3-butyl imidazolium bromide. Mixtures of solvents can also be used.
- the reaction temperature is preferably between 0 0 C and the reflux temperature of the solvent mixture, preferably between 0 0 C and 180 0 C, and more preferably between 20° and 150 0 C.
- the reaction time is preferably from 5min to 72h, and more preferably from 1 to10h.
- the catalysts used in this reaction step are preferably primary, secondary or tertiary amines like piperidine, n-hexylamine, pyridine or triethylamine.
- the basic amines can be used as such or in combination with an acidic compound like acetic acid, benzoic acid or HCI.
- Suitable catalysts are any catalysts which are normally used in Knoevenagel reactions.
- catalysts such as a salt of an organic base with an organic acid, such as piperidinium acetate.
- the Knoevenagel condensation under conditions (b) is carried out in the presence of a tetra- alkyl orthotitanate Ti(OR ' ) (0.5 req. to 5 eq. with respect to the aldehyde) as decribed for example in K. Yamashita et al., Tetrahedron 2005, 61, 7981-7985.
- Solvents used in this step are alcohols ROH, for example ethanol, methanol, isopropanol, n-propanol, n-butanol, 2- methyl-1-butanol, isobutanol, 2-butanol, 2-pentanol.
- solvents are benzene, toluene, o-xylene, m-xylene, p-xylene, chloroform, dichloromethane, tetrahydrofurane, acetonitrile, ethyl acetate, CCI 4 , cyclohexane, n-hexane, n-pentane, or ionic liquids as for example 1-methyl-3-butyl imidazolium bromide. Mixtures of solvents can also be used.
- the reaction temperature is preferably between -10 0 C and the reflux temperature of the solvent mixture, preferably between 0°C and 180°C, and more preferably between 20° and 150 0 C.
- Knoevenagel condensation under conditions (c) is carried out in the presence of a titanium tetrachloride TiCI 4 (0.5 req. to 5 eq. with respect to the aldehyde) as decribed for example in W. Lehnert, Tetrahedron Letters 1970, 54, 4723-4724 or in H. Chen et al., Eur. J. Org. Chem. 2006, 2329-2335.
- TiCI 4 0.5 req. to 5 eq. with respect to the aldehyde
- Solvents used in this step are ethers like tetrahydrofurane, dioxane, tert-butyl-methylether, diethyl ether, or alcohols ROH, for example ethanol, methanol, isopropanol, n-propanol, n-butanol, 2-methyl-1-butanol, isobutanol, 2-butanol, 2- pentanol.
- ethers like tetrahydrofurane, dioxane, tert-butyl-methylether, diethyl ether, or alcohols ROH, for example ethanol, methanol, isopropanol, n-propanol, n-butanol, 2-methyl-1-butanol, isobutanol, 2-butanol, 2- pentanol.
- solvents are benzene, toluene, o-xylene, m-xylene, p-xylene, chloroform, dichloromethane, tetrahydrofurane, acetonitrile, ethyl acetate, CCI 4 , cyclohexane, n-hexane, n-pentane, or ionic liquids as for example 1-methyl-3-butyl imidazolium bromide. Mixtures of solvents can also be used.
- the reaction temperature is preferably between -10 0 C and the reflux temperature of the solvent mixture, preferably between 0 0 C and 180 0 C, and more preferably between 20° and 150 0 C.
- the monomeric benzylidene malonates according to formula (1 ) are suitable especially as UV filters, that is to say for the protection of organic materials that are sensitive to ultraviolet light, especially human and animal skin and hair, against the action of UV radiation.
- Such compounds are accordingly suitable as light-protective agents in cosmetic, pharmaceutical and veterinary medicine preparations. Such compounds are preferably used in the dissolved state.
- the invention accordingly relates also to a cosmetic preparation comprising at least one compound of formula (1 ), and cosmetically tolerable carriers or adjuvants.
- the cosmetic preparation may also comprise, in addition to the UV absorber according to the invention, one or more further UV protective agents of the following substance classes: p-aminobenzoic acid derivatives, salicylic acid derivatives, benzophenone derivatives, diben- zoylmethane derivatives, diphenylacrylates, 3-imidazol-4-yl acrylic acid and esters; benzo- furan derivatives, polymeric UV absorbers, cinnamic acid derivatives, camphor derivatives, hydroxyphenyltriazine compounds, benzotriazole compounds, trianilino-s-triazine derivatives, 2-phenylbenzimidazole-5-sulfonic acid and salts thereof; menthyl o-aminobenzoate; merocy- anine derivatives; encapsulated UV absorbers, 4,4-diphenyl-1 ,3-butadiene derivatives, tris- (aryl) triazines, TiC>2, ZnO and mica.
- UV absorbers described in "Sunscreens", Eds. NJ. Lowe, N.A.Shaath, Marcel Dekker, Inc. , New York and Basle or in Cosmetics & Toiletries (107), 50ff (1992) also can be used as additional UV protective substances. Special preference is given to the light-protective agents indicated in the following Table 2:
- BEMT Tinosorb S, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine encapsulated in a polymer matrix, for example in PMMA, as described in IP.com Journal (2009), 9(1 B), 17, can also be used as additional UV protective substance.
- each of the above-mentioned light-protective agents can be used in admixture with the UV absorbers according to the invention. It will be understood in that connection that, in addition to the UV absorbers according to the invention, it is also possible for more than one of the additional light-protective agents to be used, for example, two, three, four, five or six further light- protective agents. Preference is given to the use of mixing ratios of UV absorbers according to the invention/further light-protective agents of from 1 :99 to 99:1 , especially from 1 :95 to 95:1 and preferably from 10:90 to 90:10, based on weight. Of special interest are mixing ratios of from 20:80 to 80:20, especially from 40:60 to 60:40 and preferably of approximately 50:50. Such mixtures can be used, inter alia, to improve solubility or to increase UV absorption.
- the benzylidene malonates according to the present invention are used - in combination with at least one additional oil soluble UV filter in combination with at least one additional water soluble UV filter in combination with at least one additional insoluble soluble UV filter in combination with at least one additional insoluble organic UV filter in combination with at least one additional insoluble inorganic UV filter in combination with at least one additional organic UV filter in combination with at least one additional inorganic UV filter in combination with at lest one additional organic/inorganid hybrid material UV filter in combination with at lest one additional encapsulated UV filter in combination with at lest one additional polymeric UV filter.
- each specific UV absorber (based on the weight of all UV absorbers in the combination) can for example range from 0.01 to 0.99, especially 0.1 to 0.9, preferably 0.2 to 0.8. (for example 0.3).
- UV filter combination examples are the following: In all of the UV filter combinations listed before the weight ratio of the UV absorbers (based on the weight of all UV absorbers in the combination) is:
- the new UV filter may be (as described in Table 1 ) MBM-01 or MBM-02 or MBM-03 or MBM- 04 or MBM-05 or MBM-06 or MBM-07 or MBM-081 or MBM-09 or MBM-10 or MBM-11 or MBM-12.
- UV SOL may be (as described in Table 2) UV SOL 1 , or UV SOL 2, or UV SOL 3, or UV SOL 4, or UV SOL 5, or UV SOL 6, or UV SOL 7, or UV SOL 8, or UV SOL 9, or UV SOL 10, or UV SOL 11, or UV SOL 12, or UV SOL 13, or UV SOL 14, or UV SOL 15, or UV SOL 16, or UV SOL 17, or UV SOL 18, or UV SOL 19, or UV SOL 20, or UV SOL 21 , or UV SOL 22, or UV SOL 23, or UV SOL 24, or UV SOL 25, or UV SOL 26, or UV SOL 27, or UV SOL 28, or UV SOL 29, or UV SOL 30, or UV SOL 31 , or UV SOL 32, or UV SOL 33, or UV SOL 34, or UV SOL 35, or UV SOL 36, or UV SOL 37, or UV SOL 38, or UV SOL 39, or UV SOL 40, or UV SOL 41 , or UV SOL 42, or UV SOL 43, or UV SOL 44,
- UV LIQ may be (as described in Table 3) UV LIQ 1 , or UV LIQ 2, or UV LIQ 3, or UV LIQ 4, or UV LIQ 5, or UV LIQ 6, or UV LIQ 7, or UV LIQ 8, or UV LIQ 9, or UV LIQ 10, or UV LIQ 1 1 , or UV LIQ 12, or UV LIQ 13, or UV LIQ 14, or UV LIQ 15, or UV LIQ 16, or UV LIQ 17, or UV LIQ 18, or UV LIQ 19, or UV LIQ 20, or UV LIQ 21 , or UV LIQ 22, or UV LIQ 23, or UV LIQ 24, or UV LIQ 25, or UV LIQ 26, or UV LIQ 27, or UV LIQ 28, or UV LIQ 29, or UV LIQ 30, or UV LIQ 31 , or UV LIQ 32, or UV LIQ 33, or UV LIQ 34, or UV LIQ 35, or UV LIQ 36, or UV LIQ 37, or UV LIQ 38, or UV LIQ 39, or UV LIQ 40, or UV LIQ 41 , or UV LIQ 42, or UV LIQ 43, or UV LIQ 40
- UV WAT may be (as described in Table 4) UV WAT 1 , or UV WAT 2, or UV WAT 3, or UV WAT 4, or UV WAT 5, or UV WAT 6, or UV WAT 7, or UV WAT 8, or UV WAT 9, or UV WAT 10, or UV WAT 1 1 , or UV WAT 12, or UV WAT 13, or UV WAT 14, or UV WAT 15, or UV WAT 16, or UV WAT 17, or UV WAT 18, or UV WAT 19, or UV WAT 20, or UV WAT 21 , or UV WAT 22, or UV WAT 23, or UV WAT 24, or UV WAT 25, or UV WAT 26, or UV WAT 27, or UV WAT 28, or UV WAT 29, or UV WAT 30, or UV WAT 31 , or UV WAT 32, or UV WAT 33, or UV WAT 34, or UV WAT 35, or UV WAT 36, or UV WAT 37, or UV WAT 38, or UV WAT 39, or UV WAT 40, or UV WAT 41 , or UV WAT 42, or UV WAT 43, or UV WAT 40
- the invention relates also to cosmetic compositions that comprise at least one of the UV absorbers according to the invention.
- the cosmetic compositions are suitable especially as UV filters, that is to say for the protection of organic materials that are sensitive to ultraviolet light, especially skin and hair, against the damaging action of UV radiation.
- the cosmetic compositions contain, for example, from 0.1 to 30 % by weight, preferably from 0.1 to 15 % by weight and especially from 0.5 to 10 % by weight, based on the total weight of the composition, of one or more UV absorbers and at least one cosmetically tolerable adjuvant.
- the cosmetic compositions can be prepared by physically mixing the UV absorber(s) with the adjuvant using customary methods, for example by simply stirring together the individual components, especially by making use of the dissolution properties of already known cosmetic UV absorbers, for example OMC, salicylic acid isooctyl ester, inter alia.
- the UV absorber can be used, for example, without further treatment.
- the cosmetic compositions may be, for example, creams, gels, lotions, alcoholic and aqueous/alcoholic solutions, emulsions, wax/fat compositions, stick preparations, powders or ointments.
- compositions according to the invention may in addition contain, as further adjuvants and additives, mild surfactants, super-fatting agents, pearlescent waxes, consistency regulators, thickeners, polymers, silicone compounds, fats, waxes, stabilisers, biogenic active ingredients, deodorising active ingredients, anti-dandruff agents, film formers, swelling agents, further UV light-protective factors, antioxidants, hydrotropic agents, preservatives, insect repellents, self-tanning agents, solubilisers, perfume oils, colourants, bacteria-inhibiting agents and the like.
- mild surfactants super-fatting agents
- pearlescent waxes consistency regulators, thickeners, polymers, silicone compounds, fats, waxes, stabilisers, biogenic active ingredients, deodorising active ingredients, anti-dandruff agents, film formers, swelling agents, further UV light-protective factors, antioxidants, hydrotropic agents, preservatives, insect repellents, self-tanning agents, solubilisers, perfume oils, colour
- Cosmetic formulations according to the invention are contained in a wide variety of cosmetic preparations. There come into consideration, for example, especially the following preparations: skin-care preparations, bath preparations, skin-care preparations, cosmetic personal care preparations, foot-care preparations, light-protective preparations, skin-tanning preparations, depigmenting preparations, insect-repellents, deodorants, antiperspirants, preparations for cleansing and caring for blemished skin, hair-removal preparations in chemical form (depilation), shaving preparations, fragrance preparations, cosmetic hair- treatment preparations.
- liquid preparations as a W/O, O/W, 0/W/O, W/O/W or PIT emulsion and all kinds of microemulsions,
- cosmetic compositions for the skin are light-protective preparations, such as sun milks, lotions, creams, oils, sunblocks or tropicals, pretanning preparations or after-sun preparations, also skin-tanning preparations, for example self-tanning creams.
- light-protective preparations such as sun milks, lotions, creams, oils, sunblocks or tropicals
- pretanning preparations or after-sun preparations also skin-tanning preparations, for example self-tanning creams.
- sun protection creams, sun protection lotions, sun protection oils, sun protection milk and sun protection preparations in the form of a spray are particularly useful for sun protection cream.
- hair-washing preparations in the form of shampoos, hair conditioners, hair-care preparations, e.g. pretreatment preparations, hair tonics, styling creams, styling gels, pomades, hair rinses, treatment packs, intensive hair treatments, hair-straightening preparations, liquid hair-setting preparations, hair foams and hairsprays.
- hair-washing preparations in the form of shampoos.
- the cosmetic preparation according to the invention contains from 0.1 to 15 % by weight, preferably from 0.5 to 10 % by weight, based on the total weight of the composition, of a UV absorber of formula (1 ) or of a mixture of UV absorbers and a cosmetically tolerable adjuvant.
- the cosmetic preparation can be prepared by physically mixing the UV absorber or UV absorbers with the adjuvant using conventional methods, for example by simply stirring the individual components together.
- the cosmetic preparation according to the invention can be formulated as a water-in-oil or oil-in-water emulsion, as an oil-in-alcohol lotion, as a vesicular dispersion of an ionic or non- ionic amphiphilic lipid, as a gel, solid stick or as an aerosol formulation.
- the cosmetically tolerable adjuvant preferably contains from 5 to 50 % of an oil phase, from 5 to 20 % of an emulsifier and from 30 to 90 % water.
- the oil phase can comprise any oil suitable for cosmetic formulations, for example one or more hydrocarbon oils, a wax, a natural oil, a silicone oil, a fatty acid ester or a fatty alcohol.
- Preferred mono- or poly-ols are ethanol, isopropanol, propylene glycol, hexylene glycol, glycerol and sorbitol.
- any conventionally usable emulsifier for example one or more ethoxylated esters of natural derivatives, for example polyethoxylated esters of hydrogenated castor oil, or a silicone oil emulsifier, for example silicone polyol; an unethoxylated or ethoxylated fatty acid soap; an ethoxylated fatty alcohol; an unethoxylated or ethoxylated sorbitan ester; an ethoxylated fatty acid; or an ethoxylated glyceride.
- the cosmetic preparation according to the invention is distinguished by excellent protection of human skin against the damaging effect of sunlight.
- reaction mixture is cooled to room temperature before 0.5 M aq. HCI (200 ml) and EtOAc (200 ml) are added.
- the phases are separated and the organic phase is washed with water (200ml), brine (200ml) and dried over Na 2 SO 4 .
- reaction mixture is stirred at 0 0 C for 2h and then at room temperature overnight.
- the organic layer is separated, washed with brine, saturated aqueous NaHCO 3 solution and dried over Na 2 SO 4 .
- the solvent is removed under reduced pressure using a rotary evaporator to yield 4- methoxybenzylidene-di-(1-methylbutyl)-malonate (7.17 g, 99%).
- the product may be further purified by Kugelrohr distillation under high vacuum.
- This compound can be prepared by Knoevenagel condensation of diisopropyl malonate with 4-ethoxybenzaldehyde analogously to example 14.
- Example 16 4-n-Propoxybenzylidene-di-isopropyl-malonate
- This compound can be prepared by Knoevenagel condensation of diisopropyl malonate with 4-n-propoxybenzaldehyde analogously to example 14.
- This compound can be prepared by Knoevenagel condensation of diisopropyl malonate with 4-n-butoxybenzaldehyde analogously to example 14.
- the organic layer is separated and washed with brine and saturated aqueous NaHCC>3 solution, dried over Na 2 SO 4 , and the solvent is removed under reduced pressure using a rotary evaporator.
- Di-(1 , 1-dimethlpropyl)-malonate is prepared by base catalyzed transesterification of dimethyl malonate or diethyl malonate with 2-methyl-2-butanol as described in EP278914.
- di-(1 ,1-dimethlpropyl)-malonate is prepared by reaction of malonyl dichloride with 2-methyl-2-butanol:
- the combined ether extracts are washed once with 6 N H 2 SO 4 , twice with water, twice with 10% aqueous K 2 CO 3 solution, and once with brine, and are finally dried over Na 2 SO 4 to which a small amount of K 2 CO 3 is added.
- the solvent is removed under reduced pressure using a rotary evaporator.
- the residue is then distilled under reduced pressure (bp. 113-1 14°C/10 mbar) to yield di-(1 ,1-dimethylpropyl)- malonate (1 1.4 g, 47%).
- the sample is applied on sand blasted PMMA plates (delivered by Helioscience, Marseille, France) with an application amount of 1 ,4 mg/cm 2 , irradiated with an Atlas CPS+ solar simulator and tested in an Optometries SPF 290 analyzer.
- the calculation of the in vitro SPF is done according to B. L. Diffey and J. Robson, J. Soc. Cosmet. Chem. 1989, 40, 127-133.
- the in vitro SPF is determined to be 5.0.
- the photostability of Butyl 4-Methoxybenzylidene-di-tert-butyl-malonate is determined by spreading the emulsion as a 20 ⁇ m thick film on four quartz plates. The plates are irradiated using a solar simulator for 1 h (5 MED), 2 h (10 MED), 4 h (20 MED) and 10 h (50 MED). After the indicated irradiation times one of the quartz plate is plunged into 5 ml of tetrahydro- furane. The amount of UV-B filter 4-Methoxybenzylidene-di-tert-butyl-malonate is then determined using high performance liquid chromatography.
- the residual 4-Methoxybenzyli- dene-di-tert-butyl-malonate is determined to be 100% ( ⁇ 1 %) in all cases.
- 4-Methoxy- benzylidene-di-tert-butyl-malonate shows complete photostability in an O/W sunscreen formulation.
- the formulation is prepared as described above for formulation A.
- the sample is applied on sand blasted PMMA plates (delivered by Helioscience, Marseille, France) with an application amount of 1 ,4 mg/cm 2 , irradiated with an Atlas CPS+ solar simulator and tested in an Optometries SPF 290 analyzer.
- the calculation of the in vitro SPF is done according to B. L. Diffey and J. Robson, J. Soc. Cosmet. Chem. 1989, 40, 127-133.
- the in vitro SPF is determined to be 5.3.
- the photostability of Butyl Methoxydibenzoylmethane is determined by spreading the emulsion as a 20 ⁇ m thick film on a quartz plate. The film is irradiated using a solar simulator for 2 h (10 MED). After irradiation, the quartz plate is plunged into 5 ml of tetrahydrofurane. The amount of UV-A filter Butyl Methoxydibenzoylmethane is then determined using high performance liquid chromatography. The residual Butyl Methoxydibenzoylmethane is determined to be 47%.
- the formulation is prepared as described above for formulation A.
- the photostability of Butyl Methoxydibenzoylmethane in the comparative formulation C is determined as described above for formulation B.
- the residual Butyl Methoxydibenzoylmethane is determined to be 4%.
- the recovery of Butyl Methoxydibenzoylmethane has been shown to be 11.75 times higher in the presence of 4-Methoxybenzylidene-di-tert-butyl- malonate (compound of example 17).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020147022870A KR20140112561A (en) | 2009-05-29 | 2010-05-19 | Benzylidene malonates |
EP10723020.3A EP2435017B1 (en) | 2009-05-29 | 2010-05-19 | Benzylidene malonates |
ES10723020T ES2766259T3 (en) | 2009-05-29 | 2010-05-19 | Benzylidene malonates |
CN201080023625.XA CN102448429B (en) | 2009-05-29 | 2010-05-19 | Toluenyl malonic ester |
US13/322,628 US20120128745A1 (en) | 2009-05-29 | 2010-05-19 | Benzylidene malonates |
BRPI1011417A BRPI1011417A2 (en) | 2009-05-29 | 2010-05-19 | use of benzylidene malonates, cosmetic preparation, and benzylidene malonates. |
KR1020147022866A KR101621638B1 (en) | 2009-05-29 | 2010-05-19 | Benzylidene malonates |
JP2012512306A JP5722312B2 (en) | 2009-05-29 | 2010-05-19 | Benzylidene malonates |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09161452.9 | 2009-05-29 | ||
EP09161452 | 2009-05-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010136360A2 true WO2010136360A2 (en) | 2010-12-02 |
WO2010136360A3 WO2010136360A3 (en) | 2011-11-24 |
Family
ID=41435440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2010/056843 WO2010136360A2 (en) | 2009-05-29 | 2010-05-19 | Benzylidene malonates |
Country Status (8)
Country | Link |
---|---|
US (1) | US20120128745A1 (en) |
EP (1) | EP2435017B1 (en) |
JP (1) | JP5722312B2 (en) |
KR (3) | KR20140112561A (en) |
CN (1) | CN102448429B (en) |
BR (1) | BRPI1011417A2 (en) |
ES (1) | ES2766259T3 (en) |
WO (1) | WO2010136360A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011003774A3 (en) * | 2009-07-07 | 2011-04-21 | Basf Se | Uv filter combinations comprising benzylidene malonates |
EP3305279A1 (en) | 2016-10-05 | 2018-04-11 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymer composition |
WO2018065341A1 (en) | 2016-10-05 | 2018-04-12 | Basf Se | Ultraviolet radiation absorbing polymer composition |
US10278910B2 (en) | 2012-06-28 | 2019-05-07 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polymer |
EP3556748A1 (en) | 2018-04-20 | 2019-10-23 | Basf Se | Hydroxyphenyl-triazine uv absorbers |
US10874603B2 (en) | 2014-05-12 | 2020-12-29 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing a UV-absorbing polyglycerol and a non-UV-absorbing polyglycerol |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113563183B (en) * | 2021-07-26 | 2022-11-08 | 长沙袁昌荣新材料有限公司 | Process for producing malonate compound |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4457911A (en) * | 1981-01-28 | 1984-07-03 | Van Dyk & Company Inc. | Dialkyl malonates as organic sunscreen adjuvants |
US5624663A (en) * | 1987-08-28 | 1997-04-29 | L'oreal | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates |
JPH0987234A (en) * | 1995-09-20 | 1997-03-31 | Kao Corp | Ultraviolet light absorber for skin and hair, and skin preparation for external use and hair cosmetic containing the same |
JP4117742B2 (en) * | 2003-01-28 | 2008-07-16 | ロレアル | Photoprotective compositions based on methyltrialkylsilanes having cinnamate, cinnamamide, benzalmalonamide or benzalmalonate functional groups |
JP5311607B2 (en) * | 2007-02-23 | 2013-10-09 | 株式会社 資生堂 | Skin or hair composition |
KR20100099285A (en) * | 2007-12-14 | 2010-09-10 | 바스프 에스이 | Sunscreen compositions comprising colour pigments |
-
2010
- 2010-05-19 KR KR1020147022870A patent/KR20140112561A/en not_active Application Discontinuation
- 2010-05-19 US US13/322,628 patent/US20120128745A1/en not_active Abandoned
- 2010-05-19 BR BRPI1011417A patent/BRPI1011417A2/en active IP Right Grant
- 2010-05-19 WO PCT/EP2010/056843 patent/WO2010136360A2/en active Application Filing
- 2010-05-19 CN CN201080023625.XA patent/CN102448429B/en active Active
- 2010-05-19 EP EP10723020.3A patent/EP2435017B1/en active Active
- 2010-05-19 JP JP2012512306A patent/JP5722312B2/en active Active
- 2010-05-19 KR KR1020117031277A patent/KR20120018812A/en not_active Application Discontinuation
- 2010-05-19 KR KR1020147022866A patent/KR101621638B1/en active IP Right Grant
- 2010-05-19 ES ES10723020T patent/ES2766259T3/en active Active
Non-Patent Citations (7)
Title |
---|
B. L. DIFFEY; J. ROBSON, J. SOC. COSMET. CHEM., vol. 40, 1989, pages 127 - 133 |
BASLE, COSMETICS & TOILETRIES, 1992, pages 50 |
H. CHEN ET AL., EUR. J. ORG. CHEM., 2006, pages 2329 - 2335 |
IP.COM JOURNAL, vol. 9, no. 1 B, 2009, pages 17 |
JONES; GURNOS, KNOEVENAGEL CONDENSATION. ORGANIC REACTIONS (NEW YORK), vol. 15, 1967, pages 204 - 599 |
K. YAMASHITA ET AL., TETRAHEDRON, vol. 61, 2005, pages 7981 - 7985 |
W. LEHNERT, TETRAHEDRON LETTERS, vol. 54, 1970, pages 4723 - 4724 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011003774A3 (en) * | 2009-07-07 | 2011-04-21 | Basf Se | Uv filter combinations comprising benzylidene malonates |
US9764169B2 (en) | 2009-07-07 | 2017-09-19 | Basf Se | UV filter combinations comprising benzylidene malonates |
US10278910B2 (en) | 2012-06-28 | 2019-05-07 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polymer |
US10874603B2 (en) | 2014-05-12 | 2020-12-29 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing a UV-absorbing polyglycerol and a non-UV-absorbing polyglycerol |
EP3305279A1 (en) | 2016-10-05 | 2018-04-11 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymer composition |
WO2018065341A1 (en) | 2016-10-05 | 2018-04-12 | Basf Se | Ultraviolet radiation absorbing polymer composition |
US10596087B2 (en) | 2016-10-05 | 2020-03-24 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymer composition |
US10874597B2 (en) | 2016-10-05 | 2020-12-29 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymer composition |
US11046814B2 (en) | 2016-10-05 | 2021-06-29 | Basf Se | Ultraviolet radiation absorbing polymer composition |
EP3556748A1 (en) | 2018-04-20 | 2019-10-23 | Basf Se | Hydroxyphenyl-triazine uv absorbers |
Also Published As
Publication number | Publication date |
---|---|
US20120128745A1 (en) | 2012-05-24 |
EP2435017A2 (en) | 2012-04-04 |
KR20120018812A (en) | 2012-03-05 |
KR20140112561A (en) | 2014-09-23 |
KR20140114434A (en) | 2014-09-26 |
CN102448429B (en) | 2018-03-06 |
WO2010136360A3 (en) | 2011-11-24 |
EP2435017B1 (en) | 2019-10-23 |
BRPI1011417A2 (en) | 2016-03-15 |
KR101621638B1 (en) | 2016-05-16 |
ES2766259T3 (en) | 2020-06-12 |
CN102448429A (en) | 2012-05-09 |
JP5722312B2 (en) | 2015-05-20 |
JP2012528098A (en) | 2012-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101390075B1 (en) | Uv filter combinations comprising benzylidene malonates | |
US7772242B2 (en) | Merocyanine derivatives | |
DK1868984T3 (en) | BENZOIC ACID ESTER COMPOUNDS, COMPOSITIONS, APPLICATIONS AND PROCEDURES | |
EP2435017A2 (en) | Benzylidene malonates | |
AU2003298343B2 (en) | Amino substituted hydroxyphenyl benzophenone derivatives | |
DE10055940A1 (en) | New indanylid compounds | |
WO2007071582A1 (en) | Merocyanine derivatives | |
AU622195B2 (en) | New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics | |
JP2011517321A (en) | Dimeric benzylidene malonates | |
WO2009003934A1 (en) | Preparation of nanoscalar uv absorbers | |
AU705235B2 (en) | Photostable cosmetic light screening compositions | |
JPH04134041A (en) | P-xylidene ketone derivative, ultraviolet absorber containing said derivative and cosmetic containing said absorber | |
EP1981895B1 (en) | Hydroxybenzophenone derivatives | |
BRPI1011417B1 (en) | USE OF BENZYLIDEN MALONATES, COSMETIC PREPARATION, AND BENZYLIDEN MALONATES. | |
JPH04290842A (en) | Benzoylpinacolone derivative, ultraviolet light absorber and cosmetic containing the same derivative | |
JPH11255711A (en) | Naphthylpropenoic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080023625.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10723020 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010723020 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012512306 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9859/CHENP/2011 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 20117031277 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13322628 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI1011417 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: PI1011417 Country of ref document: BR Kind code of ref document: A2 Effective date: 20111129 |